Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Jan-12-19 | Dec-31-18 | Jan-12-18 |
| Revenues | 36.3 | 13.3 | 15.4 | 15.4 | 4.5 | |
| Revenue growth | 172.8% | -13.6% | 241.8% | | | |
| Cost of goods sold | 1.3 | 1.3 | 0.2 | 0.2 | 0.1 | |
| Gross profit | 35.0 | 12.0 | 15.1 | 15.1 | 4.4 | |
| Gross margin | 96.4% | 90.2% | 98.4% | 98.4% | 98.0% | |
| Selling, general and administrative | | | | | 0.0 | |
| General and administrative | 0.3 | 0.3 | 0.3 | 0.3 | 0.0 | |
| EBIT | 34.7 | 11.7 | 14.8 | 14.8 | 4.4 | |
| EBIT margin | 95.5% | 88.1% | 96.3% | 96.3% | 98.0% | |
| Pre-tax income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Net income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Net margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| |
| Diluted EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Shares outstanding (diluted) | 12,849.3 | 4,964.8 | 4,065.5 | 4,065.5 | 1,989.6 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|